Brief: Clover Biopharmaceuticals Launches Covid-19 Booster Vaccine In PRC
14/02/2023 04:04
Feb 14 (Reuters) - Clover Biopharmaceuticals Ltd
2197.HK :
* LAUNCHES COVID-19 BOOSTER VACCINE IN PEOPLE'S REPUBLIC OF
CHINA
* STARTED LAUNCH PREPARATION ACTIVITIES OF COVID-19 BOOSTER
VACCINE IN MULTIPLE PROVINCES, EXPECTED LAUNCH IN Q1 2023
Source text for Eikon: ID:nHKS7P4S30
Further company coverage: 2197.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clover Biopharmaceuticals
See all newsChina's Clover Biopharma H1 revenue drops sharply, flags going-concern doubt
Brief: Clover Biopharmaceuticals Posts FY Loss Of RMB205.1 MLN
Brief: Clover Announces Positive Phase I Clinical Data For Rsv-Hmpv-Piv3 Combination Vaccines And For Rsv Re-Vaccination In Older Adults
Brief: Clover Biopharmaceuticals Posts H1 Revenue Of RMB3.3 Million
Brief: Clover Biopharmaceuticals Says It Terminates Cooperation With Adimmune